Back to search

Article

Predicting the Risk of Progression from Barrett’s Esophagus to Esophageal Adenocarcinoma with a Mass-Spectrometry-Based Proteomic Panel

2024-10-17

Abstract excerpt

<h4>Background</h4> Esophageal adenocarcinoma (EAC) is a highly aggressive cancer with poor prognosis, often arising from gastroesophageal reflux disease (GERD) and its precursor, Barrett’s esophagus (BE). Although only a small proportion of individuals with GERD or BE develop EAC, accurately identifying those at high risk is critical for early intervention. Current surveillance methods, such as endoscopy, are inv...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
78252bf0-52f9-5ea6-95be-c92d82f67193
DOI
10.1101/2024.10.16.24315346
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Predicting the Risk of Progression from Barrett’s Esophagus to Esophageal Adenocarcinoma with a Mass-Spectrometry-Based Proteomic PanelDOI 10.1101/2024.10.16.24315346
Select a neighboring publication to make it the new centre.